These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 6995835)
1. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. Broome CV; Facklam RR; Fraser DW N Engl J Med; 1980 Sep; 303(10):549-52. PubMed ID: 6995835 [TBL] [Abstract][Full Text] [Related]
2. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249 [TBL] [Abstract][Full Text] [Related]
3. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy]. Motlová J Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381 [TBL] [Abstract][Full Text] [Related]
4. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. Shapiro ED; Berg AT; Austrian R; Schroeder D; Parcells V; Margolis A; Adair RK; Clemens JD N Engl J Med; 1991 Nov; 325(21):1453-60. PubMed ID: 1944423 [TBL] [Abstract][Full Text] [Related]
5. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
15. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
16. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme. Levidiotou S; Vrioni G; Tzanakaki G; Pappa C; Gesouli H; Gartzonika C; Papamichail D; Kremastinou J FEMS Immunol Med Microbiol; 2006 Nov; 48(2):179-82. PubMed ID: 17064274 [TBL] [Abstract][Full Text] [Related]
17. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225 [TBL] [Abstract][Full Text] [Related]
18. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Campbell JF; Donohue MA; Mochizuki RB; Nevin-Woods CL; Spika JS Hawaii Med J; 1989 Dec; 48(12):513-4, 517-8. PubMed ID: 2635176 [TBL] [Abstract][Full Text] [Related]
19. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. Whitney CG; Farley MM; Hadler J; Harrison LH; Bennett NM; Lynfield R; Reingold A; Cieslak PR; Pilishvili T; Jackson D; Facklam RR; Jorgensen JH; Schuchat A; N Engl J Med; 2003 May; 348(18):1737-46. PubMed ID: 12724479 [TBL] [Abstract][Full Text] [Related]
20. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative? van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]